BR100 Increased By (0.84%)
BR30 Increased By (0.61%)
KSE100 Increased By (0.69%)
KSE30 Increased By (0.7%)
AGHA 7.77 Increased By ▲ 0.02 (0.26%)
BECO 5.20 Increased By ▲ 0.01 (0.19%)
BML 57.25 Decreased By ▼ -1.41 (-2.4%)
BOP 34.22 Increased By ▲ 0.53 (1.57%)
CNERGY 10.79 Increased By ▲ 0.18 (1.7%)
CSIL 5.40 Increased By ▲ 0.10 (1.89%)
FCCL 54.85 Increased By ▲ 1.11 (2.07%)
FFL 16.73 Increased By ▲ 0.27 (1.64%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.43 Increased By ▲ 0.15 (2.06%)
KOSM 5.76 Increased By ▲ 0.12 (2.13%)
LOTCHEM 29.74 Increased By ▲ 0.09 (0.3%)
MLCF 95.80 Decreased By ▼ -0.56 (-0.58%)
NBP 203.63 Increased By ▲ 0.10 (0.05%)
NCPL 58.00 Increased By ▲ 1.15 (2.02%)
NPL 69.30 Increased By ▲ 1.99 (2.96%)
OGDC 318.25 Increased By ▲ 0.03 (0.01%)
PACE 10.74 Increased By ▲ 0.11 (1.03%)
PAEL 42.86 Increased By ▲ 1.09 (2.61%)
PIBTL 16.89 Increased By ▲ 0.08 (0.48%)
PPL 221.35 Increased By ▲ 1.18 (0.54%)
PRL 51.70 Increased By ▲ 2.65 (5.4%)
PTC 70.82 Increased By ▲ 0.81 (1.16%)
SSGC 28.59 Decreased By ▼ -0.55 (-1.89%)
TBL 9.88 Increased By ▲ 0.11 (1.13%)
TELE 8.93 Increased By ▲ 0.11 (1.25%)
TPL 18.30 Increased By ▲ 1.13 (6.58%)
TPLP 12.93 Increased By ▲ 0.42 (3.36%)
TREET 22.75 Increased By ▲ 0.16 (0.71%)
TRG 60.00 Decreased By ▼ -0.22 (-0.37%)

KARACHI: Economic and financial analyst Ateeq ur Rahman has said shortage of medicines or their rising cost is like adding salt to injury, thus affecting the health sector as a whole. People or patients, those who are used to regular dosage of medicines for their struggle of life to survive, need an easy access to medicines.

In these inflationary conditions if the essential medicines get expensive by the day or become impossible to reach, whatever may be the reason, is not a good situation.

Less storage capacities, unavailability of raw material due to restrictions on opening of letter of credit or devaluation of currency, etc are big hurdles in the production of pharmaceutical goods, thus creating paucity and raising the cost of medicines.

This is unbearable by majority of population, most of them are either poor or deprived or middle class to afford such increase in prices.

The government and authorities should urgently look into this severe problem and address the hindrance and production at the earliest, eventually improving the supply line and reducing the cost of medicines.

Copyright Business Recorder, 2022

Comments

Comments are closed for this article.